What this study adds
SLC19A1, SLCO1B1 , and SLCO1B3 polymorphisms are
associated with altered activity of these transporters and
affects overall survival as well as toxicity levels in lung cancer
patients.
Genotyping for the SLC polymorphism could be a valuable tool
for predicting which lung cancer patients will benefit the most from
platinum-based doublet chemotherapy.